Targeting mRNA Decapping in AML

Akihide Yoshimi1, Omar Abdel-Wahab2

  • 1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.

Cancer Cell
|March 14, 2018
PubMed

Insights

Researchers discovered that acute myeloid leukemia (AML) depends on an enzyme called DCPS, which is crucial for RNA metabolism. This enzyme can be targeted with a drug, offering a potential new treatment strategy for AML patients.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Metabolism

Background:

  • Acute myeloid leukemia (AML) is a complex hematological malignancy.
  • RNA metabolism plays a critical role in cellular function and disease pathogenesis.
  • The enzyme decapping enzyme (DCPS) is involved in messenger RNA (mRNA) degradation.

Purpose of the Study:

  • To investigate the role of DCPS in acute myeloid leukemia.
  • To determine if DCPS is a potential therapeutic target in AML.

Main Methods:

  • Utilized molecular biology techniques to study DCPS function in AML cell lines.
  • Employed a clinical inhibitor of DCPS to assess its efficacy in preclinical AML models.

Main Results:

  • Identified a significant dependency of AML cells on DCPS activity.
  • Demonstrated that inhibiting DCPS effectively reduces AML cell viability and proliferation.
  • Confirmed that DCPS is a druggable target in AML.

Conclusions:

  • DCPS is essential for the survival and proliferation of acute myeloid leukemia cells.
  • Targeting DCPS with a clinical inhibitor presents a promising therapeutic strategy for AML.
  • This discovery highlights the translational potential of targeting RNA metabolism in cancer therapy.

Related Concept Videos

mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
6.7K
Regulated mRNA Transport02:22

Regulated mRNA Transport

In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.1K
Regulated mRNA Transport02:22

Regulated mRNA Transport

3.4K
pre-mRNA Processing02:01

pre-mRNA Processing

In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.6K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

5.5K